Meanwhile, SB705498 (1.0 mg kg−1) was intratumorally injected at 30 min pre-irradiation for inducing TRPV1 blockade in A549-WT tumor models followed by tumor volumes monitoring during 30 days post-injection (Supplementary Fig. 16). The gene discussed is TRPV1; the disease is neoplasm.